182 related articles for article (PubMed ID: 3486060)
21. A phorbol ester tumor promoter induces changes in the expression of immunoglobulins and DR antigens in human lymphoblastoid cells.
Roth P; Halper JP; Weinstein IB; Pernis B
J Immunol; 1982 Aug; 129(2):539-44. PubMed ID: 6979576
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of HLA class II antigens on human fetal and adult lymphocytes and macrophages.
Edwards JA; Jones DB; Evans PR; Smith JL
Immunology; 1985 Jul; 55(3):489-500. PubMed ID: 3894221
[TBL] [Abstract][Full Text] [Related]
23. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
Guy K; Van Heyningen V; Dewar E; Steel CM
Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
[TBL] [Abstract][Full Text] [Related]
24. T-24.B-cell differentiation factor induces immunoglobulin secretion in human B cells without prior cell replication.
Gallagher G; Christie JF; Stimson WH; Guy K; Dewar AE
Immunology; 1987 Apr; 60(4):523-9. PubMed ID: 3495482
[TBL] [Abstract][Full Text] [Related]
25. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
26. Serological detection of B-cell ("Ia-like") antigens in serum of normal donor and in some sera of leukaemic patients.
Koubek K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):408-15. PubMed ID: 6182060
[TBL] [Abstract][Full Text] [Related]
27. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.
Krajewski AS; Guy K; Dewar AE; Cossar D
J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225
[TBL] [Abstract][Full Text] [Related]
30. Class II alloantigen expression on leukemic cells.
Falkenrodt A; Urlacher A; Mayer S; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard S; Mitsuichi Y; Dormoy A
Nouv Rev Fr Hematol (1978); 1989; 31(3):209-16. PubMed ID: 2694093
[TBL] [Abstract][Full Text] [Related]
31. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
[TBL] [Abstract][Full Text] [Related]
32. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
33. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
Muczynski KA; Anderson SK; Pious D
J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
35. [Induced differentiation of subpopulations of leukemic blood cells in patients with chronic B-cell lympholeukemia].
Zlobina EN; Baryshnikov AIu
Biull Eksp Biol Med; 1987 Mar; 103(3):340-2. PubMed ID: 3548840
[TBL] [Abstract][Full Text] [Related]
36. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
37. Modulation of MHC class II expression in human cells by dexamethasone.
Schwiebert LM; Schleimer RP; Radka SF; Ono SJ
Cell Immunol; 1995 Oct; 165(1):12-9. PubMed ID: 7671315
[TBL] [Abstract][Full Text] [Related]
38. Non-co-ordinate expression of HLA-DR antigens and invariant chain.
Momburg F; Möller P
Immunology; 1988 Mar; 63(3):551-3. PubMed ID: 3280476
[TBL] [Abstract][Full Text] [Related]
39. Differential abilities of human peripheral blood monocytes quantitatively or qualitatively differing in HLA-DR and HLA-DS expression to support B cell activation in liquid and semisolid cultures.
Whisler RL; Newhouse YG; Lachman LB
J Immunol; 1985 Jul; 135(1):172-9. PubMed ID: 3873488
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell-specific antigen BP50 (CDW40).
Ledbetter JA; Shu G; Gallagher M; Clark EA
J Immunol; 1987 Feb; 138(3):788-94. PubMed ID: 3492534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]